Pfizer has agreed to acquire Arena Pharmaceuticals for about $6.7 billion in a deal that validates the San Diego biotech’s plan to reshape itself around a portfolio of inflammation drugs. Pfizer will buy Arena for $100 per share in cash, more than double the biotech’s closing price on Friday. More @Wikipedia
Get the latest news about Arena Pharmaceuticals from the top news sites, aggregators and blogs. Also included are videos, photos, and websites related to Arena Pharmaceuticals.
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.
Bookmark or Share